AWM
APLT

Adams Wealth Management’s Applied Therapeutics APLT Stock Holding History

Adams Wealth Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,637
Closed -$3.86K – 150
2025
Q4 		$3.86K Hold
38,637
– – ﹤0.01% 180
2025
Q3 		$22K Hold
38,637
– – ﹤0.01% 182
2025
Q2 		$12.4K Hold
38,637
– – ﹤0.01% 181
2025
Q1 		$18.5K Buy
38,637
+28,384
+277% +$16.7K ﹤0.01% 145
2024
Q4 		$8.78K Buy
+10,253
New +$64.3K ﹤0.01% 114

Adams Wealth Management's APLT Position: Q1 2026 in Review

Adams Wealth Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 38,637 shares — an estimated $3.86K sold.

Adams Wealth Management first reported a position in APLT in Q4 2024 and held it in 5 quarters. The position peaked at $22K in Q3 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • Adams Wealth Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Adams Wealth Management sold 38,637 Applied Therapeutics shares in Q1 2026, an estimated $3.86K.
  • Adams Wealth Management first reported a position in Applied Therapeutics in Q4 2024 and held it in 5 quarters.
  • Adams Wealth Management's Applied Therapeutics position peaked at $22K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Adams Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.